Finally, some good news for HIV-positive people
Because the medicine has a long-lasting effect on the body, it is usually given to patients once a month. The drug will go a long way toward alleviating the medication sluggishness that HIV positive people experience. HIV-positive people occasionally fail to take their prescriptions, particularly in the case of children who are not cared for by adults.
Islatravir isn't the only one facing charges; Cabenuva is also being tried once a month in Kenya.
Apart from these two, dolutegravir is another pharmaceutical on the way, but it will most likely be significantly better one year from now or in 2023, because dolutegravir can only be used once per year. Another tablet in the works is cabotegravir, which must be taken once a day like clockwork but is now being tested.
Content created and supplied by: Darex (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More